These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35508353)
1. Synchronous colonic B cell lymphoma and adenocarcinoma in an elderly patient treated with R-mini-CHOP followed by resection. Schep D; Van Koughnett JA; Velker V; Correa RJM BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35508353 [TBL] [Abstract][Full Text] [Related]
2. Primary colonic lymphoma: report of two cases and a literature review. Chen L; Sun Q; Chen E; Jin D; Song Z J Int Med Res; 2021 Jun; 49(6):3000605211017037. PubMed ID: 34082600 [TBL] [Abstract][Full Text] [Related]
3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147 [TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage. Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. Feugier P; Van Hoof A; Sebban C; Solal-Celigny P; Bouabdallah R; Fermé C; Christian B; Lepage E; Tilly H; Morschhauser F; Gaulard P; Salles G; Bosly A; Gisselbrecht C; Reyes F; Coiffier B J Clin Oncol; 2005 Jun; 23(18):4117-26. PubMed ID: 15867204 [TBL] [Abstract][Full Text] [Related]
11. Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study. Rutherford SC; Abramson JS; Bartlett NL; Barta SK; Khan N; Joyce R; Maddocks K; Ali-Shaw T; Senese S; Yuan Y; Westin J; Leonard JP Lancet Haematol; 2021 Nov; 8(11):e818-e827. PubMed ID: 34634256 [TBL] [Abstract][Full Text] [Related]
12. Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial. Gleeson M; Hawkes EA; Cunningham D; Chadwick N; Counsell N; Lawrie A; Jack A; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford J; McMillan A; Davies J; Turner D; Kruger A; Johnson PW; Gambell J; Linch D Br J Haematol; 2016 Nov; 175(4):668-672. PubMed ID: 27477167 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis. Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128 [TBL] [Abstract][Full Text] [Related]
14. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study. Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202 [TBL] [Abstract][Full Text] [Related]
15. Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study. Späth-Schwalbe E; Lange C; Genvresse I; Krüger L; Eucker J; Schweigert M; Sezer O; Budach V; Possinger K Anticancer Drugs; 2002 Apr; 13(4):395-403. PubMed ID: 11984085 [TBL] [Abstract][Full Text] [Related]
16. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753 [TBL] [Abstract][Full Text] [Related]
17. CHOP plus rituximab--balancing facts and opinion. Cheson BD N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154 [No Abstract] [Full Text] [Related]
18. Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP. Bewarder M; Kaddu-Mulindwa D; Kos IA; Lesan V; Held G; Poeschel V; Thurner L; Bittenbring JT; Schmitz N; Truemper L; Pfreundschuh M; Christofyllakis K; Loeffler M; Altmann B; Ziepert M Haematologica; 2023 Oct; 108(10):2844-2849. PubMed ID: 36815369 [No Abstract] [Full Text] [Related]
19. [Coexisting malignant lymphoma and advanced adenocarcinoma of the colon--a case report]. Moriya Y; Koyama Y; Minato K; Shimoyama M; Hirota T; Itabashi M Gan No Rinsho; 1985 Jun; 31(7):894-9. PubMed ID: 3928946 [TBL] [Abstract][Full Text] [Related]
20. Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version. Belia M; Drandakis I; Lakiotaki E; Arapaki M; Panitsas F; Triantafyllou EF; Plata E; Siakantaris MP; Angelopoulou MK; Korkolopoulou P; Vassilakopoulos TP Ann Hematol; 2023 Aug; 102(8):2279-2282. PubMed ID: 37115296 [No Abstract] [Full Text] [Related] [Next] [New Search]